Therefore, in line with the results of these recent studies, it is believed that the adiponectin/leptin ratio may be an important inflammatory marker that can be used to investigate comorbidities in patients with severe obesity and MetS before and after bariatric surgery. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.